ALT•benzinga•
Altimmune (ALT) Stock Rises Amid Clinical Trial Progress: What's Going On?
Summary
Altimmune stock rose on Tuesday without news, possibly due to high short interest. Its new trial for Alcohol Use Disorder and upcoming MASH results may be fueling excitement.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 20, 2025 by benzinga